These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12801045)

  • 1. Relapse patterns after chemo-radiation for carcinoma of the oesophagus.
    Denham JW; Steigler A; Kilmurray J; Wratten C; Burmeister B; Lamb DS; Joseph D; Delaney G; Christie D; Jamieson G; Smithers BM; Ackland S; Walpole E
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):98-108. PubMed ID: 12801045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG).
    Denham JW; Burmeister BH; Lamb DS; Spry NA; Joseph DJ; Hamilton CS; Yeoh E; O'Brien P; Walker QJ
    Radiother Oncol; 1996 Jul; 40(1):31-43. PubMed ID: 8844885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
    Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
    Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
    Button MR; Morgan CA; Croydon ES; Roberts SA; Crosby TD
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):818-23. PubMed ID: 18718726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
    Kawaguchi Y; Nishiyama K; Miyagi K; Suzuki O; Ito Y; Nakamura S
    Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.
    Wilson KS; Lim JT
    Radiother Oncol; 2000 Feb; 54(2):129-34. PubMed ID: 10699475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
    Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
    J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
    Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
    Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
    Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction.
    Stahl M; Vanhoefer U; Stuschke M; Walz MK; Müller C; Wilke H
    Eur J Cancer; 1998 Apr; 34(5):668-73. PubMed ID: 9713272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.
    Ajani JA; Komaki R; Putnam JB; Walsh G; Nesbitt J; Pisters PW; Lynch PM; Vaporciyan A; Smythe R; Lahoti S; Raijman I; Swisher S; Martin FD; Roth JA
    Cancer; 2001 Jul; 92(2):279-86. PubMed ID: 11466680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: a questionnaire survey in Japan.
    Aoyama N; Koizumi H; Minamide J; Yoneyama K; Isono K
    Int J Clin Oncol; 2001 Jun; 6(3):132-7. PubMed ID: 11706782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.